US Jury Orders Apple to Pay $634m to Masimo for Patent Infringement

A federal jury in California has ruled in favor of Masimo, a medical device manufacturer, ordering Apple to pay $634 million for infringing on Masimo's blood oxygen monitor patent. The jury found that Apple unlawfully incorporated Masimo's technology into its Apple Watch, leading to a significant legal setback for the tech giant.

Masimo has been engaged in a legal battle with Apple over patent infringement, with Apple planning to appeal the verdict. Masimo's commitment to defending its intellectual property rights highlights the importance of protecting innovation in the health tech sector.